ARCT
Price
$11.84
Change
+$0.25 (+2.16%)
Updated
May 13, 04:59 PM (EDT)
Capitalization
321.65M
COIN
Price
$256.91
Change
+$49.69 (+23.98%)
Updated
May 13, 04:59 PM (EDT)
Capitalization
64.23B
91 days until earnings call
Ad is loading...

ARCT vs COIN

Header iconARCT vs COIN Comparison
Open Charts ARCT vs COINBanner chart's image
Arcturus Therapeutics Holdings
Price$11.84
Change+$0.25 (+2.16%)
Volume$8.51K
Capitalization321.65M
Coinbase Global
Price$256.91
Change+$49.69 (+23.98%)
Volume$209.28K
Capitalization64.23B
ARCT vs COIN Comparison Chart
Loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COIN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARCT vs. COIN commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a Hold and COIN is a Buy.

Ad is loading...
COMPARISON
Comparison
May 14, 2025
Stock price -- (ARCT: $11.59 vs. COIN: $207.22)
Brand notoriety: ARCT and COIN are both not notable
ARCT represents the Biotechnology, while COIN is part of the Investment Banks/Brokers industry
Current volume relative to the 65-day Moving Average: ARCT: 161% vs. COIN: 148%
Market capitalization -- ARCT: $297.78M vs. COIN: $64.23B
ARCT [@Biotechnology] is valued at $297.78M. COIN’s [@Investment Banks/Brokers] market capitalization is $64.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The market cap for tickers in the [@Investment Banks/Brokers] industry ranges from $928.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B. The average market capitalization across the [@Investment Banks/Brokers] industry is $12.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileCOIN’s FA Score has 0 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • COIN’s FA Score: 0 green, 5 red.
According to our system of comparison, ARCT is a better buy in the long-term than COIN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 2 TA indicator(s) are bullish while COIN’s TA Score has 5 bullish TA indicator(s).

  • ARCT’s TA Score: 2 bullish, 6 bearish.
  • COIN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, COIN is a better buy in the short-term than ARCT.

Price Growth

ARCT (@Biotechnology) experienced а -2.77% price change this week, while COIN (@Investment Banks/Brokers) price change was +3.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.44%. For the same industry, the average monthly price growth was +10.87%, and the average quarterly price growth was -7.59%.

The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was +7.51%. For the same industry, the average monthly price growth was +20.26%, and the average quarterly price growth was +125.19%.

Reported Earning Dates

ARCT is expected to report earnings on May 12, 2025.

COIN is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Investment Banks/Brokers (+7.51% weekly)

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COIN($64.2B) has a higher market cap than ARCT($322M). COIN YTD gains are higher at: -16.545 vs. ARCT (-31.703). COIN has higher annual earnings (EBITDA): 146M vs. ARCT (-77.4M). COIN has more cash in the bank: 5.72B vs. ARCT (237M). ARCT has less debt than COIN: ARCT (28.6M) vs COIN (3B). COIN has higher revenues than ARCT: COIN (3.11B) vs ARCT (138M).
ARCTCOINARCT / COIN
Capitalization322M64.2B1%
EBITDA-77.4M146M-53%
Gain YTD-31.703-16.545192%
P/E RatioN/A681.38-
Revenue138M3.11B4%
Total Cash237M5.72B4%
Total Debt28.6M3B1%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTCOIN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
Bullish Trend 19 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COIN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ERII12.240.87
+7.65%
Energy Recovery
GFF72.934.45
+6.50%
Griffon Corp
BAX31.880.98
+3.17%
Baxter International
HOOK1.340.04
+3.08%
HOOKIPA Pharma Inc.
OPRX9.20-0.79
-7.91%
OptimizeRx Corp

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with BMEA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
+5.56%
BMEA - ARCT
52%
Loosely correlated
+8.59%
ABCL - ARCT
50%
Loosely correlated
+1.48%
TRDA - ARCT
49%
Loosely correlated
+5.25%
AXON - ARCT
49%
Loosely correlated
+1.24%
RCKT - ARCT
44%
Loosely correlated
+0.14%
More

COIN and

Correlation & Price change

A.I.dvisor indicates that over the last year, COIN has been closely correlated with RIOT. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if COIN jumps, then RIOT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COIN
1D Price
Change %
COIN100%
+3.96%
RIOT - COIN
81%
Closely correlated
+2.59%
AFRM - COIN
81%
Closely correlated
+15.79%
MSTR - COIN
81%
Closely correlated
-2.68%
CLSK - COIN
80%
Closely correlated
+4.57%
HIVE - COIN
79%
Closely correlated
+0.54%
More